Prospective, Observational Real-world Treatments of AEDH in Large-scale Surgical Cases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorRenJi Hospital
About this trial
This is a multicenter, prospective, and observational real-world study aimed at investigating the current situation of surgical treatments and prognosis for acute epidural hematoma in China, and analyzing the optimization of therapy.
Eligibility criteria
Qualifiers
Clear medical history of traumatic brain injury;
within 12 hours after injury;
Supratentorial unilateral acute epidural hematoma on first head CT scan examination;
The admitting neurosurgeon considers that the epidural hematoma needs to be evacuated with surgical treatment;
Disqualifiers
Previous intracranial surgery prior to trauma;
Patients with a score of 3 on the GCS, with bilateral fixed and dilated pupils, bleeding diathesis or defective coagulation, or an injury that was deemed to be unsurvivable;
CT demonstrates associated other intracranial hematomas e.g. subdural, intracerebral hemorrhage, or large size infarction, which are the main causes of operation;
Patients who had injury of the oculomotor nerve;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
RenJi Hospital
Lead sponsor
Clinical Research Institute, Shanghai Jiao Tong University School of Medicine
Collaborator
Shenzhen Second People's Hospital
Collaborator
Source ClinicalTrials.gov